Selectis Health Announces CFO Resignation and Interim Appointment

On January 17, 2025, Selectis Health, Inc. (OTCMKTS: GBCS) saw the resignation of James Creamer from his position as Chief Financial Officer. This departure was formalized through a Separation Agreement and Release on the same date. In light of Creamer’s resignation, Adam Desmond, the current CEO of Selectis Health, will step in as the Interim CFO until a suitable candidate is found to fill the role permanently. The Separation Agreement and Release, marked as Exhibit 10.1, captures the terms of Creamer’s departure.

Under Item 9.01, Selectis Health filed the Separation Agreement and Release as well as the Cover Page Interactive Data File, as exhibited in the Inline XBRL document.

Following the departure, Adam Desmond, CEO of Selectis Health, signed the Form 8-K on behalf of the company as required by the Securities Exchange Act of 1934. The document was officially signed on January 23, 2025, marking the transition established within the executive team.

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Selectis Health’s 8K filing here.

About Selectis Health

(Get Free Report)

Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents.

Read More